We are live on ! Find out more
NBRV

Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV

Delisted

NBRV was delisted on the 31st of July, 2023.

Back to rankings

53 hedge funds and large institutions have $21.7M invested in Nabriva Therapeutics plc Ordinary Shares Ireland in 2020 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 12 increasing their positions, 6 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

103,600% more call options, than puts

Call options by funds: $1.04M | Put options by funds: $1K

100% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 6

51% more capital invested

Capital invested by funds: $14.3M → $21.7M (+$7.36M)

30% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 10

6% more funds holding

Funds holding: 50 → 53 (+3)

Holders
53
Holders Change
+3
Holders Change %
+6%
% of All Funds
1.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
12
Reduced
6
Closed
10
Calls
$1.04M
Puts
$1K
Net Calls
+$1.04M
Net Calls Change
+$846K

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$5.46M
2
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
+$3.64M
3
GIM
Granahan Investment Management
Massachusetts
+$750K
4
State Street
State Street
Massachusetts
+$538K
5
WG
Winton Group
United Kingdom
+$245K

Top Sellers

Rank Fund Capital Flow
1
VC
Vivo Capital
California
-$980K
2
FNC
First National Corp
Massachusetts
-$941K
3
SM
Sabby Management
Florida
-$211K
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$145K
5
Renaissance Technologies
Renaissance Technologies
New York
-$131K
Name Holding Trade Value Shares
Change 		Change in
Stake
PPA
26
Parametric Portfolio Associates
Washington
$28K -$2.5K -15 -8%
PCS
27
Personal CFO Solutions
New Jersey
$27K – – –
RJA
28
Raymond James & Associates
Florida
$27K – – –
ARTA
29
A.R.T. Advisors
New York
$22K +$22K +132 New
SWM
30
SeaCrest Wealth Management
New York
$21K – – –
SIAP
31
Sterling Investment Advisors (Pennsylvania)
Pennsylvania
$20K – – –
Jane Street
32
Jane Street
New York
$19K +$7.67K +46 +66%
EC
33
Estate Counselors
Wisconsin
$16K +$16.3K +98 New
WS
34
Wedbush Securities
California
$14K – – –
GF
35
Gabelli Funds
New York
$12K – – –
CFD
36
Creative Financial Designs
Indiana
$11K -$6K -36 -36%
BF
37
BOK Financial
Oklahoma
$10K +$10K +60 New
Goldman Sachs
38
Goldman Sachs
New York
$9K -$70.9K -425 -89%
AFA
39
American Financial Advisors
Georgia
$9K – – –
First Manhattan
40
First Manhattan
New York
$8K – – –
ECM
41
ETrade Capital Management
Virginia
$8K +$8.34K +50 New
BB
42
Bell Bank
North Dakota
$7K – – –
LPL Financial
43
LPL Financial
California
$7K – – –
TRCT
44
Tower Research Capital (TRC)
New York
$7K – – –
BG
45
Bollard Group
Massachusetts
$7K +$6.67K +40 New
SPIA
46
Steward Partners Investment Advisory
New York
$6K – – –
CFG
47
Citizens Financial Group
Rhode Island
$3K – – –
Royal Bank of Canada
48
Royal Bank of Canada
Ontario, Canada
$3K +$1.33K +8 +57%
PAG
49
Private Advisor Group
New Jersey
$3K +$2.67K +16 New
Osaic Holdings
50
Osaic Holdings
Arizona
$3K +$3.33K +20 New
1
2
3

NBRV Hedge Fund Activity: Q2 2020 in Review

53 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) for Q2 2020, worth a combined $21.7M — up 51% from $14.3M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new NBRV positions and 10 closed out — a net gain of 3 holders — while 12 added to existing stakes and 6 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $5.46M. The largest seller was Vivo Capital, exiting entirely with an estimated $980K sold.

  • 53 institutional investors held Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) as of Q2 2020, up from 50 in Q1 2020.
  • Funds reported $21.7M of Nabriva Therapeutics plc Ordinary Shares Ireland stock for Q2 2020, up 51% quarter-over-quarter.
  • 13 funds opened new Nabriva Therapeutics plc Ordinary Shares Ireland positions in Q2 2020 and 10 closed out, a net change of +3 holders.
  • The largest Nabriva Therapeutics plc Ordinary Shares Ireland buyer in Q2 2020 was Fidelity Investments, an estimated $5.46M added.
  • The largest Nabriva Therapeutics plc Ordinary Shares Ireland seller in Q2 2020 was Vivo Capital, an estimated $980K sold.

Based on aggregated 13F filings for Q2 2020.